Windtree Therapeutics, a Nasdaq listed biotechnology company, has plans to raise up to $200 million to build a treasury of ...

Anthem Biosciences Ltd.'s ₹3,395-crore initial public offering (IPO) in 2025 was oversubscribed by 63.86 times due to strong ...

At the facility developed in partnership with the distillery, Meridian Biotech will convert Buffalo Trace's by-products ...

The initial public offering (IPO) allotment status for Anthem Biosciences is expected to be finalized today, Thursday, July ...

Funding will be used to establish the clinical utility of OneMap™, a proprietary artificial intelligence (AI) driven single cell transcriptomic oncology ...

The initial public offer of Anthem Biosciences received bids for 2,81,45,24,128 shares as against 4,40,70,682 shares on offer. The issue was subscribed 63.86 times.

Anthem Biosciences IPO Allotment status, Anthem IPO GMP Price: Anthem Biosciences IPO allotment status set to go live today after oversubscription; check your allotment now!

The IPO of Anthem Biosciences is now heading toward its next big step and that is ‘share allotment’, which is expected to be ...

Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours: Taipei, Taiwan Thursday, July 17, 202 ...

Kfin Technologies is the registrar for the Anthem Biosciences IPO. Follow these steps to check your allotment status: Visit the Registrar’s Website: Go to the Kfin Technologies’ portal at ...

Investors can check the status of their IPO allotment on July 17 through the website of the registrar, Kfin Technologies Ltd, by entering their PAN or application number. The allotment status will ...

VERAXA Biotech AG ('VERAXA” or the 'Company'), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp.,  a Cayman Islands exempted company and special purpose acquisition ...